Bringing The World Home To You

© 2024 WUNC North Carolina Public Radio
120 Friday Center Dr
Chapel Hill, NC 27517
919.445.9150 | 800.962.9862

Donate

Play Live Radio

Next Up:

0:00

0:00 0:00

Available On Air Stations

WUNC End of Year - Make your tax-deductible gift!

Court Files Yield New Information in Suit Against Drugmaker

By Snigdha Prakash

Published November 2, 2002 at 12:00 AM EST

Documents filed in a federal lawsuit against Parke Davis shed more light on allegations that the drug manufacturer marketed the anti-seizure drug Neurontin for various unauthorized uses. NPR's Snigdha Prakash reports.

Snigdha Prakash

Pieces by National Desk reporter Snigdha Prakash can be heard on NPR's All Things Considered and Morning Edition. The majority of Snigdha's past reports have focused on topics related to entrepreneurship, business, banking and the economy.

Stories From This Author

The Plot Thickens with a Generic Blood Thinner

Snigdha Prakash

A small Canadian firm takes on two of the largest drug companies in the world with its surprise launch of a generic copy of the best-selling blood thinner Plavis. Apotex began shipping its generic version to U.S. stores today. The makers of Plavix sold $6 billion of the popular heart drug last year.
Medical Journal Issues Vioxx Study Correction

Snigdha Prakash

A correction published today on the New England Journal of Medicine's Web site undermines a key feature of Merck's defense against the thousands of lawsuits filed over its painkiller Vioxx.
Data: Vioxx Heart Risks Began Earlier than Thought

Snigdha Prakash

New data obtained by NPR about the painkiller Vioxx show that all patients who took the drug were at increased risk for heart attack, stroke and other complications -- even those who took it for short periods of time. About 20 million Americans are estimated to have taken Vioxx before it was withdrawn in 2004.